The incidence of EGFR mutation is higher in nonsmokers, patients with lung adenocarcinoma, those with lymph node metastasis, those with high-expression CEA, and those with low-expression Cy21-1. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.